Solar Foods starts Factory01
Following market authorisation in Singapore two years ago, the Finnish company Solar Foods Oy and the Japanese food giant Ajinomoto Group want to...
Friday: CRISPR screen highlights genes behind T cell plasticity in autoimmunity
Pro-inflammatory CD4-positive T cells are major drivers of autoimmune diseases, yet therapiesmodulating T cell phenotypes to promote an...
CordenPharma invests €900m in peptide patform expansion
CordenPharma has announced its largest strategic investment to date with a committed spend of ~€900m over the next 3 years to grow its peptide...
Consortium led by Evotec enters obesity drug space
The newly formed strategic partnership between Evotec SE, Inserm, Lille University Hospital and Inserm Transfert aims to identify novel multimodal...
No more needles - Exvolvo arises with help of Verily and NLC Health
NLC Health Ventures launches a new early-stage drug delivery company. The venture builder from The Netherlands partners with Verily from which Exolvo...
LabGenius raises £35m to expand its antibody discovery platform
The investment brings LabGenius’ total funding to £58m. The new round was led by new investor M Ventures (Merck’s venture capital). New investors...
Biotalys starts field testing for biofungicide
The protein-based biofungicide is under development of the company’s Agrobody technology platform for sustainable biocontrols as an alternative...